The disease is still so new, and testing so limited, that the usual methods of analysis epidemiologists rely on are not yet viable.
from Health https://ift.tt/32Ws0KU
March 08, 2020
Rose
Health, Health - The New York Times
No comments
Related Posts:
Novavax Covid Vaccine Wins Authorization in IndonesiaAfter months of production delays, this is the first vaccine authorization for Novavax and its manufacturing partner, the Serum Institute of India. from NYT > Health https://ift.tt/3GF7B0s … Read More
Budget Plan Offers Fix for Medicaid Coverage Gap, for NowThe $1.85 trillion social policy bill would provide free private health insurance for more than two million adults locked out of coverage, but only for four years. from NYT > Health https://ift.tt/3nHqYx6 … Read More
Dr. Aaron T. Beck, Developer of Cognitive Therapy, Dies at 100It was an answer to Freudian analysis: a pragmatic, thought-monitoring approach to treating anxiety, depression and other mental disorders, and it changed psychiatry. from NYT > Health https://ift.tt/2ZKmcqg … Read More
Muriel Lezak, Leading Authority on Brain Injuries, Dies at 94A neuropsychologist, she wrote a textbook that became an essential guide to describing and evaluating brain damage and dysfunction. from NYT > Health https://ift.tt/3mugmCt … Read More
Chronic Kidney Disease May Be Over-Diagnosed in ElderlyMany men and women with “failing kidneys” may not have anything more than a normal age-related decline in kidney function. from NYT > Health https://ift.tt/2Y6et5J … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment